Completed PHASE1 INTERVENTIONAL 4-arm NCT01231997

Clinical Study to Investigate the Safety and Pharmacokinetics of Udenafil Tablet in Renal Impaired Male Patients (DA8159_RI_I)

Sponsor: Asan Medical Center

Conditions Kidney Diseases Renal Insufficiency Urologic Diseases

Interventions Udenafil

Updated 5 times since 2017 Last updated: Nov 1, 2010 Started: Nov 30, 2009 Primary completion: Nov 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01231997, this PHASE1 trial focuses on Kidney Diseases and Renal Insufficiency and remains completed. Sponsored by Asan Medical Center, it has been updated 5 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE1
Sep 2024 — Sep 2025 [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jan 2017 — Jan 2021 [monthly]

Completed PHASE1

First recorded

Nov 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Asan Medical Center
Dong-A Pharmaceutical Co., Ltd.

Data source: Asan Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea